About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

November 10, 2016

Click here to read more

Post navigation

2016 Sep 12 Phosphagenics Updates Long Term Incentive Scheme

ProPhase Arbitration Ruling Handed Down

Related Posts

Phosphagenics Signs Term Sheet for TPM Diclofenac Gel in Asia

September 26, 2017

Phosphagenics Receives Further Arbitration Process Update

October 23, 2018

Change of Company Name and ASX Code

May 24, 2019August 28, 2019

Recent Posts

$5.06m Placement Complete
February 9, 2021
Interview with Peter Switzer
January 19, 2021
Observational study testing enhanced CBD formulation
December 22, 2020

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.